BRAF mutations in aberrant crypt foci and hyperplastic polyposis

被引:89
作者
Beach, R
Chan, AOO
Wu, TT
White, JA
Morris, JS
Lunagomez, S
Broaddus, RR
Issa, JPJ
Hamilton, SR
Rashid, A
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[4] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China
关键词
D O I
10.1016/S0002-9440(10)62327-9
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Patients with hyperplastic polyposis have multiple hyperplastic polyps (HPs) and increased risk of colorectal carcinomas. Aberrant crypt foci (ACF) are postulated to be the earliest precursor lesions in colorectal carcinogenesis. We evaluated BRAF mutations by DNA sequencing in 53 ACF from patients with sporadic colorectal carcinomas and familial adenomatous polyposis, in 18 sporadic HPs from patients with resected colorectal can cer, and in 70 HPs, 4 serrated adenomas, 3 admixed hyperplastic-adenomatous polyps, 10 tubular adenomas, and 6 carcinomas from 17 patients with multiple/large HPs and/or hyperplastic polyposis. BRAF mutation status was compared with clinicopathological features and other genetic alterations by marginal logistic regression. BRAF mutation was present in only 2% of ACF and 6% of sporadic HPs. In contrast, BRAF mutation was present in 43% of BIPS (P = 0.01 versus sporadic HPs), 75% of serrated adenomas, 33% of admixed hyperplastic-adenomatous polyps, 30% of tubular adenomas, and 33% of carcinomas from patients with multiple/large HPs and/or hyperplastic polyposis. BRAF mutation status in patients with multiple/large HPs and/or hyperplastic polyposis correlated with HPs from the same patient (odds ratio, 5.8; P = 0.0002) but associated with younger age (odds ratio, 0.83; P = 0.006 compared to older age), with a large UP (odds ratio, 22.5; P = 0.01 compared with patients with multiple HPs), with location of HPs in the right colon (odds ratio, 3.0; P = 0.03), and with methylation of the pi 6 gene and the MINT31 locus [odds ratio, 12.2 (P = 0.0001) and 4.4 (P = 0.02), respectively]. our study shows that BRAF mutation status is heterogeneous among patients with multiple/large HPs and/or hyper plastic polyposis, suggesting differences in pathogenesis of HPs that indicate subsets within this phenotype.
引用
收藏
页码:1069 / 1075
页数:7
相关论文
共 49 条
  • [21] Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum
    Jass, JR
    Iino, H
    Ruszkiewicz, A
    Painter, D
    Solomon, MJ
    Koorey, DJ
    Cohn, D
    Furlong, KL
    Walsh, MD
    Palazzo, J
    Edmonston, TB
    Fishel, R
    Young, J
    Leggett, BA
    [J]. GUT, 2000, 47 (01) : 43 - 49
  • [22] Emerging concepts in colorectal neoplasia
    Jass, JR
    Whitehall, VLJ
    Young, J
    Leggett, BA
    [J]. GASTROENTEROLOGY, 2002, 123 (03) : 862 - 876
  • [23] JEN J, 1994, CANCER RES, V54, P5523
  • [24] BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum
    Kambara, T
    Simms, LA
    Whitehall, VLJ
    Spring, KJ
    Wynter, CVA
    Walsh, MD
    Barker, MA
    Arnold, S
    McGivern, A
    Matsubara, N
    Tanaka, N
    Higuchi, T
    Young, J
    Jass, JR
    Leggett, BA
    [J]. GUT, 2004, 53 (08) : 1137 - 1144
  • [25] COLONIC ADENOCARCINOMA IN A PATIENT WITH MULTIPLE HYPERPLASTIC POLYPS
    LIEVERSE, RJ
    KIBBELAAR, RE
    GRIFFIOEN, G
    LAMERS, CBHW
    [J]. NETHERLANDS JOURNAL OF MEDICINE, 1995, 46 (04) : 185 - 188
  • [26] MIXED HYPERPLASTIC ADENOMATOUS POLYPS SERRATED ADENOMAS - A DISTINCT FORM OF COLORECTAL NEOPLASIA
    LONGACRE, TA
    FENOGLIOPREISER, CM
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1990, 14 (06) : 524 - 537
  • [27] LOTHE RA, 1993, CANCER RES, V53, P5849
  • [28] DELETION OF IP LOCI AND MICROSATELLITE INSTABILITY IN COLORECTAL POLYPS
    LOTHE, RA
    ANDERSEN, SN
    HOFSTAD, B
    MELING, GI
    PELTOMAKI, P
    HEIM, S
    BROGGER, A
    VATN, M
    ROGNUM, TO
    BORRESEN, AL
    [J]. GENES CHROMOSOMES & CANCER, 1995, 14 (03) : 182 - 188
  • [29] MCCANN BG, 1988, HISTOPATHOLOGY, V13, P700
  • [30] MUKAI K, 1997, GUT, V40, P660